Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction [Phase 4]
This clinical trial update describes a prospective, single-arm study evaluating irinotecan liposome injection with platinum-based chemothera…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy [Phase 2]
A Phase 2 trial is investigating hypofractionated radiotherapy followed by chemo-immunotherapy induction in limited-stage small cell lung ca…
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating adebrelimab plus apatinib mesylate and chemotherapy as neoadjuvant therapy for limited-stage small cell lung cancer…
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: TH1902 in Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for TH1902 in patients with advanced solid tumors. The study is currently active/not recruiting and …
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating pembrolizumab plus lenvatinib and chemotherapy as first-line treatment for extensive-stage small cell…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Lung Cancer Registry
A ClinicalTrials.gov registry entry for the Lung Cancer Registry (NCT04654364) shows the study is currently recruiting. The conditions inclu…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC) [Phase 2]
Phase 2 clinical trial evaluating serplulimab with chemotherapy as neoadjuvant therapy for limited-stage small cell lung cancer; recruitment…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer [Phase 2]
Phase 2 trial evaluating dose-attenuated chemotherapy in compromised patients with lung cancer is currently recruiting. The study includes b…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
This clinical trial update announces ongoing recruitment for the TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO study led by Un…
-
CLINICAL_TRIALS research · 2025-03-31Clinical Trial Update: SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type
The document reports a not-yet-recruiting clinical trial evaluating a SERS-based serum spectral screening method for lung cancer type differ…
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
A recruiting study evaluating genomic and methylation markers to predict resistance to chemo-immunotherapy in small cell lung cancer and lar…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: A Multicenter Cancer Biospecimen Collection Study
A multicenter cancer biospecimen collection trial sponsored by Cofactor Genomics is currently recruiting, covering multiple cancer indicatio…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer [Phase 1]
Phase 1 study evaluating adding BAY 1895344 to standard chemotherapy for advanced solid tumors, focusing on small cell lung cancer, poorly d…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Tislelizumab in Combination with Chemotherapy ± Radiotherapy for Extensive-Stage Oligometastatic Small Cell Lung Cancer. [Phase 2]
Phase 2 trial evaluating tislelizumab with chemotherapy, with or without radiotherapy, for extensive-stage oligometastatic small cell lung c…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors [Phase 1, Phase 2]
Clinical trial update on a Phase 1/2 study evaluating AL3818 in combination with nivolumab for solid tumors; the trial is currently not recr…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
A clinical trial registry entry for a platform study evaluating molecular testing, treatment, and outcomes in non-small cell lung cancer and…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Etoposide Plus Benmelstobart Followed by Maintenance Therapy of Benmelstobart Plus Anlotinib in First-line Treatment of Elderly Patients with Extensive Stage Small Cell Lung Cancer: a Single-arm, Prospective Trial
A single-arm prospective clinical trial in elderly patients with extensive-stage small cell lung cancer evaluating etoposide plus benmelstob…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer [Phase 3]
A Phase III trial evaluating YL201 for relapsed small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer [Phase 1]
This ClinicalTrials.gov update announces a Phase 1 study of IBI3009 in participants with unresectable, metastatic or extensive-stage small c…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study [Phase 2]
A Phase 2 prospective, single-arm multicenter study to evaluate irinotecan liposome II in combination with ivonescimab as second-line therap…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: a Study of QL1706 or QL1604 in Patients With Limited-stage Small Cell Lung Cancer After Chemoradiotherapy. [Phase 3]
A Phase 3 clinical trial evaluating QL1706 or QL1604 in patients with limited-stage small cell lung cancer after chemoradiotherapy; status i…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC [Phase 2]
Phase 2 clinical trial update on a chemotherapy-immunotherapy-based split-course adaptive hypofractionated radiotherapy for extensive-stage …
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Proteomics in Small Cell Lung Cancer
Clinical trial update noting a proteomics study in small cell lung cancer is currently recruiting at Aalborg University Hospital.
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia [Phase 2]
A Phase 2 trial of nanocrystalline Megestrol plus an immunochemotherapy regimen as first-line therapy for cachexia in extensive-stage small …
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of CBX-12 in adults with advanced or metastatic refractory solid tumors. The trial includes multiple cancer types and is cur…